Hypopharyngeal cancer secondary prevention: Difference between revisions
Line 29: | Line 29: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
CT Scan/MRI | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Imaging studies are performed at routine intervals as follows: | |||
*Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient | *Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient | ||
*Scanning for asymptomatic patients is not recommended | *Scanning for asymptomatic patients is not recommended |
Revision as of 19:18, 12 October 2015
Hypopharyngeal cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypopharyngeal cancer secondary prevention On the Web |
American Roentgen Ray Society Images of Hypopharyngeal cancer secondary prevention |
Risk calculators and risk factors for Hypopharyngeal cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Secondary prevention measures of hypopharyngeal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.[1]
Secondary Prevention
Follow up after treatment
Patients treated for hypopharyngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1]
Follow up | Description |
---|---|
|
|
|
|
CT Scan/MRI |
Imaging studies are performed at routine intervals as follows:
|
|
|
|
|
Table adapted from Pfister DG, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(8):917-23.[1]